{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:08:02Z","timestamp":1759936082310,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministries of Health and of Higher Education and Research"},{"name":"Laboratoire National de Sant\u00e9"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2017.12.041","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T16:12:36Z","timestamp":1514995956000},"page":"899-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg, 2012"],"prefix":"10.1016","volume":"36","author":[{"given":"Judith M.","family":"H\u00fcbschen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Weicherding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.12.041_b0005","unstructured":"WHO. WHO vaccine-preventable diseases: monitoring system. 2016 global summary 2016 [updated 15.07.2016]. Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=LUX."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.12.041_b0010","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/infdis\/jir067","article-title":"Who gets measles in Europe?","volume":"204","author":"Muscat","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.041_b0015","unstructured":"Luxembourg Ministry of Foreign and European Affairs. Rapport d'activit\u00e9 2016. Available from: http:\/\/www.gouvernement.lu\/6806551\/2016-rapport-affaires-etrangeres-europeennes.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.041_b0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S0950268805005789","article-title":"Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg","volume":"134","author":"Mossong","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2017.12.041_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0950268803001584","article-title":"Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study","volume":"132","author":"Mossong","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.041_b0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S0950268805005662","article-title":"Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000","volume":"134","author":"Mossong","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.12.041_b0035","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report for 2015 \u2013 Hepatitis C. Available from: http:\/\/ecdc.europa.eu\/en\/healthtopics\/hepatitis_C\/Pages\/Annual-Epidemiological-Report-for-2015.aspx."},{"key":"10.1016\/j.vaccine.2017.12.041_b0040","unstructured":"WHO. Hepatitis C - Fact sheet 2016 [updated July 2016]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/."},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.041_b0045","first-page":"314","article-title":"Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples","volume":"5","author":"Gill","year":"2002","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.vaccine.2017.12.041_b0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2458-8-386","article-title":"Assessment of measles immunity among infants in Maputo City, Mozambique","volume":"8","author":"Jani","year":"2008","journal-title":"BMC Public Health"},{"issue":"9668","key":"10.1016\/j.vaccine.2017.12.041_b0055","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(09)60142-2","article-title":"Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey","volume":"373","author":"Lowther","year":"2009","journal-title":"Lancet"},{"issue":"37","key":"10.1016\/j.vaccine.2017.12.041_b0060","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2008.07.005","article-title":"Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys","volume":"26","author":"Nigatu","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.041_b0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S0950268808000848","article-title":"Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models","volume":"137","author":"Ohuma","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.041_b0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jviromet.2013.07.014","article-title":"Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh","volume":"193","author":"Hayford","year":"2013","journal-title":"J Virol Meth"},{"issue":"5","key":"10.1016\/j.vaccine.2017.12.041_b0075","first-page":"668","article-title":"Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees","volume":"12","author":"Kremer","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.12.041_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-0934(99)00116-0","article-title":"Detection of measles specific IgG in oral fluid using an FITC\/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA)","volume":"83","author":"Nigatu","year":"1999","journal-title":"J Virol Meth"},{"issue":"7","key":"10.1016\/j.vaccine.2017.12.041_b0085","first-page":"588","article-title":"Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia","volume":"79","author":"Nokes","year":"2001","journal-title":"Bull World Health Org"},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.041_b0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-3156.1998.00227.x","article-title":"A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia","volume":"3","author":"Nokes","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.041_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jviromet.2003.09.008","article-title":"Validation of a modified commercial assay for the detection of rubella-specific IgG in oral fluid for use in population studies","volume":"114","author":"Ben Salah","year":"2003","journal-title":"J Virol Meth"},{"issue":"6","key":"10.1016\/j.vaccine.2017.12.041_b0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10096-008-0460-3","article-title":"Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts","volume":"27","author":"Vainio","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.041_b0105","unstructured":"Simple Interactive Statistical Analysis. Two by two table analysis. Available from: http:\/\/www.quantitativeskills.com\/sisa\/statistics\/twoby2.htm."},{"issue":"6","key":"10.1016\/j.vaccine.2017.12.041_b0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jadohealth.2005.08.009","article-title":"Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents","volume":"37","author":"Huang","year":"2005","journal-title":"J Adolesc Health"},{"issue":"10","key":"10.1016\/j.vaccine.2017.12.041_b0115","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2017.12.041_b0120","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.vaccine.2005.12.015","article-title":"Waning antibodies in measles and rubella vaccinees\u2013a longitudinal study","volume":"24","author":"Kremer","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2017.12.041_b0125","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-Muller","year":"2012","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.vaccine.2017.12.041_b0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1586\/14760584.2014.946015","article-title":"Review of the laboratory approaches to the detection of antibody and cell-mediated immunity to pertussis disease and vaccine","volume":"13","author":"Edwards","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.041_b0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4161\/hv.27734","article-title":"Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China","volume":"10","author":"Xiong","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.12.041_b0140","unstructured":"WHO. Mumps 2016 [updated 03.11.2016]. Available from: http:\/\/www.who.int\/immunization\/diseases\/mumps\/en\/."},{"key":"10.1016\/j.vaccine.2017.12.041_b0145","unstructured":"WHO. Measles - Fact sheet 2017 [updated March 2017]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs286\/en\/."},{"key":"10.1016\/j.vaccine.2017.12.041_b0150","unstructured":"WHO. Rubella - Fact sheet 2017 [updated March 2017]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs367\/en\/."},{"issue":"33","key":"10.1016\/j.vaccine.2017.12.041_b0155","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.33.20879","article-title":"Mumps outbreak in the Federation of Bosnia and Herzegovina with large cohorts of susceptibles and genetically diverse strains of genotype G, Bosnia and Herzegovina, December 2010 to September 2012","volume":"19","author":"Hukic","year":"2014","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.041_b0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S0950268811000707","article-title":"An outbreak of rubella in the Federation of Bosnia and Herzegovina between December 2009 and May 2010 indicates failure to vaccinate during wartime (1992\u20131995)","volume":"140","author":"Hukic","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2017.12.041_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.02.005","article-title":"Epidemiologic and laboratory surveillance of the measles outbreak in the Federation of Bosnia and Herzegovina, February 2014-April 2015","volume":"22","author":"Salimovic-Besic","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2017.12.041_b0170","doi-asserted-by":"crossref","first-page":"e74754","DOI":"10.1371\/journal.pone.0074754","article-title":"Measles outbreak in Macedonia: epidemiological, clinical and laboratory findings and identification of susceptible cohorts","volume":"8","author":"Kondova","year":"2013","journal-title":"PloS One"},{"issue":"23","key":"10.1016\/j.vaccine.2017.12.041_b0175","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.23.19586-en","article-title":"Mumps outbreak in the former Yugoslav Republic of Macedonia, January 2008-June 2009: epidemiology and control measures","volume":"15","author":"Kuzmanovska","year":"2010","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2017.12.041_b0180","first-page":"109","article-title":"Increasing incidence of rubella in Republika Srpska in the period 2006\u20132010","volume":"9","author":"Cejic","year":"2012","journal-title":"Med Glas (Zenica)"},{"issue":"10","key":"10.1016\/j.vaccine.2017.12.041_b0185","doi-asserted-by":"crossref","first-page":"e0139815","DOI":"10.1371\/journal.pone.0139815","article-title":"A Mumps Outbreak in Vojvodina, Serbia, in 2012 underlines the need for additional vaccination opportunities for young adults","volume":"10","author":"Nedeljkovic","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.vaccine.2017.12.041_b0190","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S0950268815002277","article-title":"Resurgence of measles in Serbia 2010\u20132011 highlights the need for supplementary immunization activities","volume":"144","author":"Nedeljkovic","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.041_b0195","first-page":"E070315.2","article-title":"Current measles outbreak in Serbia: a preliminary report","volume":"12","author":"Seguliev","year":"2007","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2017.12.041_b0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000326","article-title":"Syphilis, hepatitis C and HIV in Eastern Europe","volume":"30","author":"Bailey","year":"2017","journal-title":"Curr Opin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17317942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17317942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:36Z","timestamp":1759400676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17317942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X17317942"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg, 2012","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}